Target ID |
Target Type |
Target Name |
Target Organism |
Activity Type |
Activity Relation |
Value |
Unit |
Reference |
NPT1858 |
Individual Protein |
Dopamine D2 receptor |
Rattus norvegicus |
Ki |
= |
2.2 |
nM |
PMID[564774] |
NPT288 |
Individual Protein |
Serotonin 1a (5-HT1a) receptor |
Rattus norvegicus |
Ki |
= |
411.0 |
nM |
PMID[564774] |
NPT1858 |
Individual Protein |
Dopamine D2 receptor |
Rattus norvegicus |
IC50 |
= |
16.0 |
nM |
PMID[564779] |
NPT1858 |
Individual Protein |
Dopamine D2 receptor |
Rattus norvegicus |
Bmax |
= |
207.0 |
fM (mg of protein)-1 |
PMID[564779] |
NPT1858 |
Individual Protein |
Dopamine D2 receptor |
Rattus norvegicus |
Kd |
= |
0.5322 |
nM |
PMID[564779] |
NPT3102 |
Individual Protein |
Beta-glucuronidase |
Rattus norvegicus |
IC50 |
= |
7800.0 |
nM |
PMID[564784] |
NPT3103 |
Individual Protein |
Lysozyme C |
Rattus norvegicus |
IC50 |
= |
9000.0 |
nM |
PMID[564784] |
NPT5187 |
Cell Line |
MCF7-DOX |
Homo sapiens |
MDR ratio |
= |
3.4 |
n.a. |
PMID[564785] |
NPT5224 |
Individual Protein |
NS3 |
Hepatitis C virus |
IC50 |
= |
700.0 |
nM |
PMID[564788] |
NPT4110 |
Individual Protein |
3-beta-hydroxysteroid-delta(8),delta(7)-isomerase |
Homo sapiens |
Ki |
= |
8.0 |
nM |
PMID[564789] |
NPT296 |
Individual Protein |
Sigma opioid receptor |
Homo sapiens |
Ki |
= |
15.0 |
nM |
PMID[564789] |
NPT4111 |
Individual Protein |
C-8 sterol isomerase |
Saccharomyces cerevisiae S288c |
Ki |
= |
500.0 |
nM |
PMID[564789] |
NPT2740 |
Cell Line |
Neutrophils |
|
Activity |
= |
5.48 |
nmol |
PMID[564790] |
NPT2740 |
Cell Line |
Neutrophils |
|
Activity |
= |
28.0 |
nmol |
PMID[564790] |
NPT2740 |
Cell Line |
Neutrophils |
|
Activity |
= |
0.54 |
nmol |
PMID[564790] |
NPT2740 |
Cell Line |
Neutrophils |
|
Inhibition |
= |
1.7 |
% |
PMID[564790] |
NPT2740 |
Cell Line |
Neutrophils |
|
Inhibition |
= |
79.5 |
% |
PMID[564790] |
NPT2740 |
Cell Line |
Neutrophils |
|
Inhibition |
= |
24.2 |
% |
PMID[564790] |
NPT2740 |
Cell Line |
Neutrophils |
|
Activity |
= |
1.23 |
nmol |
PMID[564790] |
NPT2740 |
Cell Line |
Neutrophils |
|
Activity |
= |
3.4 |
nmol |
PMID[564790] |
NPT2740 |
Cell Line |
Neutrophils |
|
Inhibition |
= |
83.3 |
% |
PMID[564790] |
NPT2740 |
Cell Line |
Neutrophils |
|
IC50 |
= |
6600.0 |
nM |
PMID[564790] |
NPT2740 |
Cell Line |
Neutrophils |
|
Activity |
= |
2.1 |
nmol |
PMID[564790] |
NPT2740 |
Cell Line |
Neutrophils |
|
Inhibition |
= |
27.6 |
% |
PMID[564790] |
NPT2740 |
Cell Line |
Neutrophils |
|
Inhibition |
= |
55.4 |
% |
PMID[564790] |
NPT2740 |
Cell Line |
Neutrophils |
|
IC50 |
= |
2700.0 |
nM |
PMID[564790] |
NPT492 |
Cell Line |
Caco-2 |
Homo sapiens |
IC10 |
= |
11.3 |
uM |
PMID[564791] |
NPT242 |
Individual Protein |
Dopamine D1 receptor |
Homo sapiens |
Activity |
= |
96.0 |
% |
PMID[564793] |
NPT243 |
Individual Protein |
Dopamine D2 receptor |
Homo sapiens |
Activity |
= |
100.0 |
% |
PMID[564793] |
NPT244 |
Individual Protein |
Dopamine D3 receptor |
Homo sapiens |
Activity |
= |
99.0 |
% |
PMID[564793] |
NPT290 |
Individual Protein |
Serotonin 2a (5-HT2a) receptor |
Homo sapiens |
Activity |
= |
99.0 |
% |
PMID[564793] |
NPT292 |
Individual Protein |
Serotonin 2c (5-HT2c) receptor |
Homo sapiens |
Activity |
= |
91.0 |
% |
PMID[564793] |
NPT2891 |
Cell Line |
H4 |
Homo sapiens |
Activity |
= |
136.58 |
% |
PMID[564796] |
NPT2891 |
Cell Line |
H4 |
Homo sapiens |
Activity |
= |
111.52 |
% |
PMID[564796] |
NPT2891 |
Cell Line |
H4 |
Homo sapiens |
Activity |
= |
94.28 |
% |
PMID[564796] |
NPT2891 |
Cell Line |
H4 |
Homo sapiens |
Activity |
= |
76.62 |
% |
PMID[564796] |
NPT2891 |
Cell Line |
H4 |
Homo sapiens |
Activity |
= |
105.6 |
% |
PMID[564796] |
NPT2891 |
Cell Line |
H4 |
Homo sapiens |
Activity |
= |
109.0 |
% |
PMID[564796] |
NPT2891 |
Cell Line |
H4 |
Homo sapiens |
Activity |
= |
124.78 |
% |
PMID[564796] |
NPT2891 |
Cell Line |
H4 |
Homo sapiens |
Activity |
= |
105.72 |
% |
PMID[564796] |
NPT2891 |
Cell Line |
H4 |
Homo sapiens |
Activity |
= |
364.24 |
% |
PMID[564796] |
NPT2891 |
Cell Line |
H4 |
Homo sapiens |
Activity |
= |
520.24 |
% |
PMID[564796] |
NPT2891 |
Cell Line |
H4 |
Homo sapiens |
Activity |
= |
1010.35 |
% |
PMID[564796] |
NPT153 |
Individual Protein |
Androgen Receptor |
Homo sapiens |
Inhibition |
= |
2.8 |
% |
PMID[564797] |
NPT1621 |
Individual Protein |
Calmodulin |
Homo sapiens |
Kd |
= |
1000.0 |
nM |
PMID[564799] |
NPT483 |
Individual Protein |
Prelamin-A/C |
Homo sapiens |
Potency |
= |
11220.2 |
nM |
PMID[564804] |
NPT163 |
Individual Protein |
Nuclear factor NF-kappa-B p105 subunit |
Homo sapiens |
Potency |
= |
11220.2 |
nM |
PMID[564805] |
NPT537 |
Individual Protein |
Ras-related protein Rab-9A |
Homo sapiens |
Potency |
= |
58047.9 |
nM |
PMID[564806] |
NPT210 |
Individual Protein |
Thyroid stimulating hormone receptor |
Homo sapiens |
Potency |
= |
31622.8 |
nM |
PMID[564805] |
NPT51 |
Individual Protein |
Microtubule-associated protein tau |
Homo sapiens |
Potency |
= |
15848.9 |
nM |
PMID[564808] |
NPT51 |
Individual Protein |
Microtubule-associated protein tau |
Homo sapiens |
Potency |
= |
1258.9 |
nM |
PMID[564807] |
NPT213 |
Individual Protein |
Cytochrome P450 2C19 |
Homo sapiens |
Potency |
= |
12589.3 |
nM |
PMID[564805] |
NPT213 |
Individual Protein |
Cytochrome P450 2C19 |
Homo sapiens |
Potency |
= |
1995.3 |
nM |
PMID[564809] |
NPT213 |
Individual Protein |
Cytochrome P450 2C19 |
Homo sapiens |
Potency |
= |
7943.3 |
nM |
PMID[564804] |
NPT51 |
Individual Protein |
Microtubule-associated protein tau |
Homo sapiens |
Potency |
= |
44668.4 |
nM |
PMID[564807] |
NPT51 |
Individual Protein |
Microtubule-associated protein tau |
Homo sapiens |
Potency |
= |
35481.3 |
nM |
PMID[564808] |
NPT53 |
Individual Protein |
4'-phosphopantetheinyl transferase ffp |
Bacillus subtilis |
Potency |
= |
63095.7 |
nM |
PMID[564807] |
NPT53 |
Individual Protein |
4'-phosphopantetheinyl transferase ffp |
Bacillus subtilis |
Potency |
= |
25118.9 |
nM |
PMID[564809] |
NPT6188 |
Individual Protein |
NADPH oxidase 1 |
Homo sapiens |
IC50 |
> |
17000.0 |
nM |
PMID[564810] |
NPT583 |
Individual Protein |
Inositol monophosphatase 1 |
Rattus norvegicus |
Potency |
= |
1412.5 |
nM |
PMID[564808] |
NPT282 |
Individual Protein |
MAP kinase ERK2 |
Homo sapiens |
Potency |
= |
25118.9 |
nM |
PMID[564805] |
NPT150 |
Individual Protein |
Anthrax lethal factor |
Bacillus anthracis |
Potency |
= |
10000.0 |
nM |
PMID[564804] |
NPT150 |
Individual Protein |
Anthrax lethal factor |
Bacillus anthracis |
Potency |
= |
25118.9 |
nM |
PMID[564805] |
NPT538 |
Individual Protein |
Niemann-Pick C1 protein |
Homo sapiens |
Potency |
= |
58047.9 |
nM |
PMID[564806] |
NPT539 |
Individual Protein |
Cellular tumor antigen p53 |
Homo sapiens |
Potency |
= |
15848.9 |
nM |
PMID[564805] |
NPT149 |
Individual Protein |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Homo sapiens |
Potency |
= |
199.5 |
nM |
PMID[564805] |
NPT539 |
Individual Protein |
Cellular tumor antigen p53 |
Homo sapiens |
Potency |
= |
19952.6 |
nM |
PMID[564805] |
NPT110 |
Individual Protein |
Cytochrome P450 2D6 |
Homo sapiens |
Potency |
= |
1000.0 |
nM |
PMID[564804] |
NPT109 |
Individual Protein |
Cytochrome P450 3A4 |
Homo sapiens |
Potency |
= |
10000.0 |
nM |
PMID[564804] |
NPT110 |
Individual Protein |
Cytochrome P450 2D6 |
Homo sapiens |
Potency |
= |
1995.3 |
nM |
PMID[564805] |
NPT110 |
Individual Protein |
Cytochrome P450 2D6 |
Homo sapiens |
Potency |
= |
316.2 |
nM |
PMID[564809] |
NPT109 |
Individual Protein |
Cytochrome P450 3A4 |
Homo sapiens |
Potency |
= |
15848.9 |
nM |
PMID[564805] |
NPT6190 |
Individual Protein |
Pleiotropic ABC efflux transporter of multiple drugs |
Saccharomyces cerevisiae S288c |
IC50 |
= |
1400.0 |
nM |
PMID[564813] |
NPT6190 |
Individual Protein |
Pleiotropic ABC efflux transporter of multiple drugs |
Saccharomyces cerevisiae S288c |
INH |
= |
8.3 |
uM |
PMID[564813] |
NPT61 |
Individual Protein |
Beta-glucocerebrosidase |
Homo sapiens |
Potency |
n.a. |
25118.9 |
nM |
PMID[564808] |
NPT64 |
Individual Protein |
ATPase family AAA domain-containing protein 5 |
Homo sapiens |
Potency |
n.a. |
16353.5 |
nM |
PMID[564806] |
NPT152 |
Individual Protein |
Nuclear factor erythroid 2-related factor 2 |
Homo sapiens |
Potency |
n.a. |
20596.2 |
nM |
PMID[564806] |
NPT532 |
Individual Protein |
Lysine-specific demethylase 4A |
Homo sapiens |
Potency |
n.a. |
15848.9 |
nM |
PMID[564817] |
NPT443 |
Individual Protein |
Histone acetyltransferase GCN5 |
Homo sapiens |
Potency |
n.a. |
15848.9 |
nM |
PMID[564804] |
NPT242 |
Individual Protein |
Dopamine D1 receptor |
Homo sapiens |
Potency |
n.a. |
891.3 |
nM |
PMID[564806] |
NPT242 |
Individual Protein |
Dopamine D1 receptor |
Homo sapiens |
Potency |
n.a. |
129.9 |
nM |
PMID[564806] |
NPT5 |
Individual Protein |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Homo sapiens |
Potency |
n.a. |
11220.2 |
nM |
PMID[564804] |
NPT5 |
Individual Protein |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Homo sapiens |
Potency |
n.a. |
26679.5 |
nM |
PMID[564806] |
NPT5 |
Individual Protein |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Homo sapiens |
Potency |
n.a. |
15848.9 |
nM |
PMID[564809] |
NPT135 |
Individual Protein |
Chromobox protein homolog 1 |
Homo sapiens |
Potency |
n.a. |
31622.8 |
nM |
PMID[564806] |
NPT1139 |
Individual Protein |
Arachidonate 15-lipoxygenase, type II |
Homo sapiens |
Potency |
n.a. |
12589.3 |
nM |
PMID[564805] |
NPT64 |
Individual Protein |
ATPase family AAA domain-containing protein 5 |
Homo sapiens |
Potency |
n.a. |
20587.8 |
nM |
PMID[564806] |
NPT110 |
Individual Protein |
Cytochrome P450 2D6 |
Homo sapiens |
AC50 |
= |
1995.26 |
nM |
PMID[564805] |
NPT109 |
Individual Protein |
Cytochrome P450 3A4 |
Homo sapiens |
AC50 |
= |
10000.0 |
nM |
PMID[564804] |
NPT213 |
Individual Protein |
Cytochrome P450 2C19 |
Homo sapiens |
AC50 |
= |
7943.28 |
nM |
PMID[564804] |
NPT208 |
Individual Protein |
Cytochrome P450 1A2 |
Homo sapiens |
AC50 |
= |
630.96 |
nM |
PMID[564804] |
NPT208 |
Individual Protein |
Cytochrome P450 1A2 |
Homo sapiens |
AC50 |
= |
1000.0 |
nM |
PMID[564805] |
NPT213 |
Individual Protein |
Cytochrome P450 2C19 |
Homo sapiens |
AC50 |
= |
12589.25 |
nM |
PMID[564805] |
NPT109 |
Individual Protein |
Cytochrome P450 3A4 |
Homo sapiens |
AC50 |
= |
15848.93 |
nM |
PMID[564805] |
NPT110 |
Individual Protein |
Cytochrome P450 2D6 |
Homo sapiens |
AC50 |
= |
1000.0 |
nM |
PMID[564804] |
NPT198 |
Individual Protein |
Vitamin D receptor |
Homo sapiens |
Potency |
n.a. |
56234.1 |
nM |
PMID[564806] |
NPT478 |
Individual Protein |
Ataxin-2 |
Homo sapiens |
Potency |
n.a. |
17782.8 |
nM |
PMID[564806] |
NPT135 |
Individual Protein |
Chromobox protein homolog 1 |
Homo sapiens |
Potency |
n.a. |
79432.8 |
nM |
PMID[564817] |
NPT444 |
Individual Protein |
Ubiquitin carboxyl-terminal hydrolase 1 |
Homo sapiens |
Potency |
n.a. |
52673.2 |
nM |
PMID[564806] |
NPT65 |
Cell Line |
HepG2 |
Homo sapiens |
Potency |
n.a. |
25118.9 |
nM |
PMID[564817] |
NPT199 |
Individual Protein |
DNA polymerase kappa |
Homo sapiens |
Potency |
n.a. |
18887.6 |
nM |
PMID[564806] |
NPT154 |
Individual Protein |
Mothers against decapentaplegic homolog 3 |
Homo sapiens |
Potency |
n.a. |
35481.3 |
nM |
PMID[564817] |
NPT71 |
Cell Line |
HEK293 |
Homo sapiens |
Potency |
n.a. |
7304.8 |
nM |
PMID[564806] |
NPT71 |
Cell Line |
HEK293 |
Homo sapiens |
Potency |
n.a. |
1258.9 |
nM |
PMID[564817] |
NPT519 |
Cell Line |
SH-SY5Y |
Homo sapiens |
Potency |
n.a. |
28183.8 |
nM |
PMID[564806] |
NPT444 |
Individual Protein |
Ubiquitin carboxyl-terminal hydrolase 1 |
Homo sapiens |
Potency |
n.a. |
50118.7 |
nM |
PMID[564806] |
NPT444 |
Individual Protein |
Ubiquitin carboxyl-terminal hydrolase 1 |
Homo sapiens |
Potency |
n.a. |
56234.1 |
nM |
PMID[564809] |
NPT444 |
Individual Protein |
Ubiquitin carboxyl-terminal hydrolase 1 |
Homo sapiens |
Potency |
n.a. |
35481.3 |
nM |
PMID[564804] |
NPT445 |
Individual Protein |
Peripheral myelin protein 22 |
Rattus norvegicus |
Potency |
n.a. |
18105.6 |
nM |
PMID[564809] |
NPT10 |
Individual Protein |
Geminin |
Homo sapiens |
Potency |
n.a. |
23109.3 |
nM |
PMID[564817] |
NPT10 |
Individual Protein |
Geminin |
Homo sapiens |
Potency |
n.a. |
26608.6 |
nM |
PMID[564809] |
NPT477 |
Individual Protein |
DNA dC->dU-editing enzyme APOBEC-3G |
Homo sapiens |
Potency |
n.a. |
22387.2 |
nM |
PMID[564817] |
NPT10 |
Individual Protein |
Geminin |
Homo sapiens |
Potency |
n.a. |
29092.9 |
nM |
PMID[564817] |
NPT478 |
Individual Protein |
Ataxin-2 |
Homo sapiens |
Potency |
n.a. |
12589.3 |
nM |
PMID[564804] |
NPT478 |
Individual Protein |
Ataxin-2 |
Homo sapiens |
Potency |
n.a. |
19952.6 |
nM |
PMID[564806] |
NPT101 |
Individual Protein |
Glucagon-like peptide 1 receptor |
Homo sapiens |
Potency |
n.a. |
8912.5 |
nM |
PMID[564817] |
NPT11 |
Individual Protein |
Guanine nucleotide-binding protein G(s), subunit alpha |
Homo sapiens |
Potency |
n.a. |
25118.9 |
nM |
PMID[564817] |
NPT1043 |
Individual Protein |
Glycoprotein hormones alpha chain |
Homo sapiens |
Potency |
n.a. |
14125.4 |
nM |
PMID[564817] |
NPT2556 |
Individual Protein |
DNA-dependent protein kinase |
Homo sapiens |
IC50 |
= |
100000.0 |
nM |
PMID[564832] |
NPT6513 |
Individual Protein |
Emopamil-binding protein-like |
Homo sapiens |
Ki |
= |
3.9 |
nM |
PMID[564834] |
NPT50 |
Individual Protein |
Tyrosyl-DNA phosphodiesterase 1 |
Homo sapiens |
Potency |
n.a. |
16360.1 |
nM |
PMID[564817] |
NPT50 |
Individual Protein |
Tyrosyl-DNA phosphodiesterase 1 |
Homo sapiens |
Potency |
n.a. |
4610.9 |
nM |
PMID[564835] |
NPT50 |
Individual Protein |
Tyrosyl-DNA phosphodiesterase 1 |
Homo sapiens |
Potency |
n.a. |
3719.2 |
nM |
PMID[564836] |
NPT50 |
Individual Protein |
Tyrosyl-DNA phosphodiesterase 1 |
Homo sapiens |
Potency |
n.a. |
6613.8 |
nM |
PMID[564836] |
NPT50 |
Individual Protein |
Tyrosyl-DNA phosphodiesterase 1 |
Homo sapiens |
Potency |
n.a. |
20596.2 |
nM |
PMID[564817] |
NPT50 |
Individual Protein |
Tyrosyl-DNA phosphodiesterase 1 |
Homo sapiens |
Potency |
n.a. |
5173.5 |
nM |
PMID[564835] |
NPT1274 |
Individual Protein |
DNA repair protein RAD52 homolog |
Homo sapiens |
AC50 |
= |
13000.0 |
nM |
PMID[564817] |
NPT589 |
Individual Protein |
Serum albumin |
Bos taurus |
logKd |
= |
4.67 |
n.a. |
PMID[564839] |
NPT589 |
Individual Protein |
Serum albumin |
Bos taurus |
log K |
= |
3.8 |
n.a. |
PMID[564839] |
NPT619 |
Individual Protein |
Serum albumin |
Rattus norvegicus |
Kd |
= |
14000.0 |
nM |
PMID[564844] |
NPT1820 |
Cell Line |
NCI-H1650 |
Homo sapiens |
GI50 |
= |
12200.0 |
nM |
PMID[564845] |
NPT242 |
Individual Protein |
Dopamine D1 receptor |
Homo sapiens |
Inhibition |
> |
95.0 |
% |
PMID[564845] |
NPT243 |
Individual Protein |
Dopamine D2 receptor |
Homo sapiens |
Inhibition |
> |
95.0 |
% |
PMID[564845] |
NPT244 |
Individual Protein |
Dopamine D3 receptor |
Homo sapiens |
Inhibition |
> |
95.0 |
% |
PMID[564845] |
NPT245 |
Individual Protein |
Dopamine D4 receptor |
Homo sapiens |
Inhibition |
= |
73.0 |
% |
PMID[564845] |
NPT1811 |
Individual Protein |
Dopamine D5 receptor |
Homo sapiens |
Inhibition |
= |
81.0 |
% |
PMID[564845] |
NPT245 |
Individual Protein |
Dopamine D4 receptor |
Homo sapiens |
Inhibition |
> |
95.0 |
% |
PMID[564845] |
NPT1811 |
Individual Protein |
Dopamine D5 receptor |
Homo sapiens |
Inhibition |
> |
95.0 |
% |
PMID[564845] |
NPT549 |
Individual Protein |
Calmodulin |
Bos taurus |
Kd |
= |
3400.0 |
nM |
PMID[564847] |
NPT549 |
Individual Protein |
Calmodulin |
Bos taurus |
Kd |
= |
5000.0 |
nM |
PMID[564847] |
NPT3567 |
Individual Protein |
Calcium-dependent protein kinase 4 |
Plasmodium falciparum (isolate 3D7) |
Ki |
= |
150000.0 |
nM |
PMID[564853] |
NPT1535 |
Cell Line |
U-87 MG |
Homo sapiens |
Efficacy |
= |
79.0 |
% |
PMID[564854] |
NPT1535 |
Cell Line |
U-87 MG |
Homo sapiens |
Efficacy |
= |
82.0 |
% |
PMID[564854] |
NPT1535 |
Cell Line |
U-87 MG |
Homo sapiens |
IC50 |
= |
9900.0 |
nM |
PMID[564854] |
NPT1535 |
Cell Line |
U-87 MG |
Homo sapiens |
EC50 |
= |
13500.0 |
nM |
PMID[564854] |
NPT82 |
Cell Line |
MDA-MB-231 |
Homo sapiens |
IC50 |
= |
21580.0 |
nM |
PMID[564856] |
NPT83 |
Cell Line |
MCF7 |
Homo sapiens |
IC50 |
= |
11330.0 |
nM |
PMID[564856] |
NPT134 |
Cell Line |
SK-BR-3 |
Homo sapiens |
IC50 |
= |
15890.0 |
nM |
PMID[564856] |
NPT83 |
Cell Line |
MCF7 |
Homo sapiens |
Inhibition |
= |
63.8 |
% |
PMID[564856] |
NPT5536 |
Individual Protein |
Sarcoplasmic/endoplasmic reticulum calcium ATP-ase |
Oryctolagus cuniculus |
IC50 |
= |
45000.0 |
nM |
PMID[564857] |
NPT605 |
Organism |
Homo sapiens |
Homo sapiens |
IC50 |
= |
201800.0 |
nM |
PMID[564772] |
NPT35 |
Others |
n.a. |
|
Log S |
= |
-4.52 |
n.a. |
PMID[564773] |
NPT29 |
Organism |
Rattus norvegicus |
Rattus norvegicus |
ED50 |
= |
0.5 |
mg.kg-1 |
PMID[564774] |
NPT29 |
Organism |
Rattus norvegicus |
Rattus norvegicus |
ED50 |
= |
1.7 |
mg.kg-1 |
PMID[564774] |
NPT1776 |
Protein Family |
Serotonin 1 (5-HT1) receptor |
Rattus norvegicus |
Ki |
> |
1000.0 |
nM |
PMID[564774] |
NPT1777 |
Protein Family |
Serotonin 2 (5-HT2) receptor |
Rattus norvegicus |
Ki |
= |
5.2 |
nM |
PMID[564774] |
NPT968 |
Protein Family |
Adrenergic receptor alpha-1 |
Rattus norvegicus |
Ki |
= |
29.3 |
nM |
PMID[564774] |
NPT29 |
Organism |
Rattus norvegicus |
Rattus norvegicus |
IC50 |
= |
10100.0 |
nM |
PMID[564775] |
NPT29 |
Organism |
Rattus norvegicus |
Rattus norvegicus |
IC50 |
= |
12800.0 |
nM |
PMID[564775] |
NPT1774 |
Protein Family |
Sodium channel alpha subunits; brain (Types I, II, III) |
Homo sapiens |
IC50 |
= |
5000.0 |
nM |
PMID[564776] |
NPT1774 |
Protein Family |
Sodium channel alpha subunits; brain (Types I, II, III) |
Homo sapiens |
Inhibition |
= |
79.8 |
% |
PMID[564776] |
NPT2 |
Others |
Unspecified |
|
IC50 |
= |
500000.0 |
nM |
PMID[564777] |
NPT29 |
Organism |
Rattus norvegicus |
Rattus norvegicus |
ED50 |
= |
0.52 |
mg.kg-1 |
PMID[564778] |
NPT29 |
Organism |
Rattus norvegicus |
Rattus norvegicus |
Loss |
= |
1.2 |
% |
PMID[564778] |
NPT968 |
Protein Family |
Adrenergic receptor alpha-1 |
Rattus norvegicus |
IC50 |
= |
350.0 |
nM |
PMID[564779] |
NPT29 |
Organism |
Rattus norvegicus |
Rattus norvegicus |
ED50 |
= |
6.9 |
mg.kg-1 |
PMID[564779] |
NPT29 |
Organism |
Rattus norvegicus |
Rattus norvegicus |
ED50 |
= |
3.0 |
mg.kg-1 |
PMID[564779] |
NPT29 |
Organism |
Rattus norvegicus |
Rattus norvegicus |
ED50 |
= |
6.5 |
mg.kg-1 |
PMID[564779] |
NPT1777 |
Protein Family |
Serotonin 2 (5-HT2) receptor |
Rattus norvegicus |
Bmax |
= |
53.43 |
fM (mg of protein)-1 |
PMID[564779] |
NPT1777 |
Protein Family |
Serotonin 2 (5-HT2) receptor |
Rattus norvegicus |
Kd |
= |
1.043 |
nM |
PMID[564779] |
NPT991 |
Individual Protein |
Trypanothione reductase |
Trypanosoma cruzi |
IC50 |
= |
72000.0 |
nM |
PMID[564780] |
NPT991 |
Individual Protein |
Trypanothione reductase |
Trypanosoma cruzi |
Ki |
= |
23000.0 |
nM |
PMID[564780] |
NPT35 |
Others |
n.a. |
|
pKa |
= |
3.9 |
n.a. |
PMID[564781] |
NPT35 |
Others |
n.a. |
|
pKa |
= |
8.1 |
n.a. |
PMID[564781] |
NPT27 |
Others |
Unspecified |
|
Log k' |
= |
3.076 |
n.a. |
PMID[564782] |
NPT27 |
Others |
Unspecified |
|
Log k' |
= |
2.58 |
n.a. |
PMID[564782] |
NPT35 |
Others |
n.a. |
|
LogD |
= |
1.775 |
n.a. |
PMID[564782] |
NPT35 |
Others |
n.a. |
|
LogD |
= |
1.96 |
n.a. |
PMID[564782] |
NPT35 |
Others |
n.a. |
|
LogD |
= |
8.1 |
n.a. |
PMID[564782] |
NPT29 |
Organism |
Rattus norvegicus |
Rattus norvegicus |
Papp |
= |
3.9 |
n.a. |
PMID[564782] |
NPT29 |
Organism |
Rattus norvegicus |
Rattus norvegicus |
Log 1/ED50 |
= |
2.92 |
n.a. |
PMID[564782] |
NPT2 |
Others |
Unspecified |
|
Log K |
= |
3.91 |
n.a. |
PMID[564782] |
NPT2 |
Others |
Unspecified |
|
Activity |
= |
1.69 |
n.a. |
PMID[564782] |
NPT1284 |
Protein Family |
Protein kinase C (PKC) |
Rattus norvegicus |
IC50 |
= |
500000.0 |
nM |
PMID[564783] |
NPT29 |
Organism |
Rattus norvegicus |
Rattus norvegicus |
IC50 |
= |
6600.0 |
nM |
PMID[564784] |
NPT29 |
Organism |
Rattus norvegicus |
Rattus norvegicus |
IC50 |
= |
2700.0 |
nM |
PMID[564784] |
NPT29 |
Organism |
Rattus norvegicus |
Rattus norvegicus |
IC50 |
= |
14700.0 |
nM |
PMID[564786] |
NPT668 |
Individual Protein |
P-glycoprotein 1 |
Homo sapiens |
Ki |
= |
6500.0 |
nM |
PMID[564787] |
NPT35 |
Others |
n.a. |
|
pKa |
= |
4.04 |
n.a. |
PMID[564787] |
NPT35 |
Others |
n.a. |
|
pKa |
= |
7.61 |
n.a. |
PMID[564787] |
NPT35 |
Others |
n.a. |
|
pKa |
= |
7.81 |
n.a. |
PMID[564787] |
NPT35 |
Others |
n.a. |
|
pKa |
= |
8.1 |
n.a. |
PMID[564787] |
NPT2 |
Others |
Unspecified |
|
IC50 |
= |
13200.0 |
nM |
PMID[564792] |
NPT2 |
Others |
Unspecified |
|
IC50 |
= |
12700.0 |
nM |
PMID[564792] |
NPT88 |
Organism |
Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
= |
7.6 |
ug.mL-1 |
PMID[564793] |
NPT92 |
Individual Protein |
Serotonin 1a (5-HT1a) receptor |
Homo sapiens |
Activity |
= |
76.0 |
% |
PMID[564793] |
NPT35 |
Others |
n.a. |
|
LogP |
= |
5.03 |
n.a. |
PMID[564794] |
NPT35 |
Others |
n.a. |
|
pKa |
= |
8.08 |
n.a. |
PMID[564795] |
NPT35 |
Others |
n.a. |
|
LogP |
= |
5.03 |
n.a. |
PMID[564795] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
IC50 |
= |
12200.0 |
nM |
PMID[564798] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
IC50 |
= |
13200.0 |
nM |
PMID[564798] |
NPT1284 |
Protein Family |
Protein kinase C (PKC) |
Rattus norvegicus |
IC50 |
= |
30.0 |
ug.mL-1 |
PMID[564800] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
IC50 |
= |
11900.0 |
nM |
PMID[564801] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
IC50 |
= |
12500.0 |
nM |
PMID[564801] |
NPT6 |
Organism |
Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
= |
6000.0 |
nM |
PMID[564802] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
MIC |
= |
1024.0 |
ug.mL-1 |
PMID[564803] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
MIC |
= |
64.0 |
ug.mL-1 |
PMID[564803] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
MIC |
= |
32.0 |
ug.mL-1 |
PMID[564803] |
NPT312 |
Organism |
Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
Potency |
= |
3264.3 |
nM |
PMID[564806] |
NPT93 |
Individual Protein |
Survival motor neuron protein |
Homo sapiens |
Potency |
= |
31622.8 |
nM |
PMID[564807] |
NPT94 |
Individual Protein |
Aldehyde dehydrogenase 1A1 |
Homo sapiens |
Potency |
= |
39810.7 |
nM |
PMID[564807] |
NPT940 |
Individual Protein |
Serine/threonine-protein kinase mTOR |
Homo sapiens |
Potency |
= |
16481.6 |
nM |
PMID[564806] |
NPT792 |
Individual Protein |
Arachidonate 15-lipoxygenase |
Homo sapiens |
Potency |
= |
19952.6 |
nM |
PMID[564805] |
NPT940 |
Individual Protein |
Serine/threonine-protein kinase mTOR |
Homo sapiens |
Potency |
= |
14689.2 |
nM |
PMID[564806] |
NPT95 |
Individual Protein |
Muscarinic acetylcholine receptor M1 |
Rattus norvegicus |
Potency |
= |
10000.0 |
nM |
PMID[564805] |
NPT96 |
Individual Protein |
Thrombopoietin |
Homo sapiens |
Potency |
= |
15848.9 |
nM |
PMID[564805] |
NPT602 |
Organism |
Mycobacterium smegmatis |
Mycobacterium smegmatis |
MIC |
= |
50000.0 |
nM |
PMID[564812] |
NPT602 |
Organism |
Mycobacterium smegmatis |
Mycobacterium smegmatis |
IC50 |
= |
12350.0 |
nM |
PMID[564812] |
NPT602 |
Organism |
Mycobacterium smegmatis |
Mycobacterium smegmatis |
IC50 |
= |
12260.0 |
nM |
PMID[564812] |
NPT602 |
Organism |
Mycobacterium smegmatis |
Mycobacterium smegmatis |
IC50 |
= |
3150.0 |
nM |
PMID[564812] |
NPT26495 |
SINGLE PROTEIN |
Snq2p |
Saccharomyces cerevisiae (strain Lalvin EC1118 / Prise de mousse)(Baker's yeast) |
INH |
= |
6.9 |
uM |
PMID[564813] |
NPT2 |
Others |
Unspecified |
|
INH |
= |
9.8 |
uM |
PMID[564813] |
NPT20596 |
PHENOTYPE |
Hepatotoxicity |
n.a. |
Composite Activity - Active |
= |
0.0 |
n.a. |
PMID[564816] |
NPT20596 |
PHENOTYPE |
Hepatotoxicity |
n.a. |
Composite Activity - Marginal |
= |
0.0 |
n.a. |
PMID[564816] |
NPT800 |
Individual Protein |
M-phase phosphoprotein 8 |
Homo sapiens |
Potency |
n.a. |
37685.8 |
nM |
PMID[564806] |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
9200.0 |
nM |
PMID[564806] |
NPT27 |
Others |
Unspecified |
|
logP(lung) |
= |
1.33 |
n.a. |
PMID[564819] |
NPT2 |
Others |
Unspecified |
|
Kd |
= |
5700.0 |
nM |
PMID[564820] |
NPT2 |
Others |
Unspecified |
|
Kd |
= |
2100.0 |
nM |
PMID[564820] |
NPT2 |
Others |
Unspecified |
|
Kd |
= |
1000.0 |
nM |
PMID[564820] |
NPT2 |
Others |
Unspecified |
|
Kd |
= |
800.0 |
nM |
PMID[564820] |
NPT2 |
Others |
Unspecified |
|
Kd |
= |
500.0 |
nM |
PMID[564820] |
NPT2 |
Others |
Unspecified |
|
Ki |
= |
24.2 |
nM |
PMID[564820] |
NPT6 |
Organism |
Plasmodium falciparum |
Plasmodium falciparum |
Potency |
n.a. |
9528.3 |
nM |
PMID[564809] |
NPT698 |
Individual Protein |
Regulator of G-protein signaling 4 |
Homo sapiens |
Potency |
n.a. |
18887.6 |
nM |
PMID[564806] |
NPT6 |
Organism |
Plasmodium falciparum |
Plasmodium falciparum |
Potency |
n.a. |
16944.1 |
nM |
PMID[564809] |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
29092.9 |
nM |
PMID[564821] |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
29092.9 |
nM |
PMID[564822] |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
29092.9 |
nM |
PMID[564807] |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
29092.9 |
nM |
PMID[564823] |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
29092.9 |
nM |
PMID[564809] |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
29092.9 |
nM |
PMID[564808] |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
35481.3 |
nM |
PMID[564817] |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
6510.4 |
nM |
PMID[564806] |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
29092.9 |
nM |
PMID[564805] |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
29092.9 |
nM |
PMID[564824] |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
29092.9 |
nM |
PMID[564804] |
NPT694 |
Individual Protein |
UDP-glucuronosyltransferase 1-3 |
Homo sapiens |
Activity |
= |
0.0 |
pm/min/mg |
PMID[564825] |
NPT902 |
Individual Protein |
UDP-glucuronosyltransferase 1A4 |
Homo sapiens |
Activity |
= |
165.0 |
pm/min/mg |
PMID[564826] |
NPT98 |
Individual Protein |
HERG |
Homo sapiens |
IC50 |
= |
6226.0 |
nM |
PMID[564827] |
NPT98 |
Individual Protein |
HERG |
Homo sapiens |
Ki |
= |
5100.8 |
nM |
PMID[564827] |
NPT20596 |
PHENOTYPE |
Hepatotoxicity |
n.a. |
LTKB_BD DILI severity score |
= |
2.0 |
n.a. |
PMID[564828] |
NPT20596 |
PHENOTYPE |
Hepatotoxicity |
n.a. |
HepSE_bilirubinemia |
= |
0.0 |
n.a. |
PMID[564829] |
NPT20596 |
PHENOTYPE |
Hepatotoxicity |
n.a. |
HepSE_cholecystitis |
= |
0.0 |
n.a. |
PMID[564829] |
NPT20596 |
PHENOTYPE |
Hepatotoxicity |
n.a. |
HepSE_cholelithiasis |
= |
0.0 |
n.a. |
PMID[564829] |
NPT20596 |
PHENOTYPE |
Hepatotoxicity |
n.a. |
HepSE_cirrhosis |
= |
0.0 |
n.a. |
PMID[564829] |
NPT20596 |
PHENOTYPE |
Hepatotoxicity |
n.a. |
HepSE_elevated liver function tests |
= |
0.0 |
n.a. |
PMID[564829] |
NPT20596 |
PHENOTYPE |
Hepatotoxicity |
n.a. |
HepSE_hepatic failure |
= |
0.0 |
n.a. |
PMID[564829] |
NPT20596 |
PHENOTYPE |
Hepatotoxicity |
n.a. |
HepSE_hepatic necrosis |
= |
0.0 |
n.a. |
PMID[564829] |
NPT20596 |
PHENOTYPE |
Hepatotoxicity |
n.a. |
HepSE_hepatitis |
= |
0.0 |
n.a. |
PMID[564829] |
NPT20596 |
PHENOTYPE |
Hepatotoxicity |
n.a. |
HepSE_hepatomegaly |
= |
0.0 |
n.a. |
PMID[564829] |
NPT20596 |
PHENOTYPE |
Hepatotoxicity |
n.a. |
HepSE_jaundice |
= |
1.0 |
n.a. |
PMID[564829] |
NPT20596 |
PHENOTYPE |
Hepatotoxicity |
n.a. |
HepSE_liver disease |
= |
0.0 |
n.a. |
PMID[564829] |
NPT20596 |
PHENOTYPE |
Hepatotoxicity |
n.a. |
HepSE_liver fatty |
= |
0.0 |
n.a. |
PMID[564829] |
NPT20596 |
PHENOTYPE |
Hepatotoxicity |
n.a. |
HepSE_liver function tests abnormal |
= |
0.0 |
n.a. |
PMID[564829] |
NPT20596 |
PHENOTYPE |
Hepatotoxicity |
n.a. |
HepSE_Combined Scores |
= |
1.0 |
n.a. |
PMID[564829] |
NPT888 |
Individual Protein |
78 kDa glucose-regulated protein |
Homo sapiens |
Potency |
n.a. |
52119.4 |
nM |
PMID[564806] |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
22793.6 |
nM |
PMID[564809] |
NPT668 |
Individual Protein |
P-glycoprotein 1 |
Homo sapiens |
IC50 |
= |
10900.0 |
nM |
PMID[564830] |
NPT668 |
Individual Protein |
P-glycoprotein 1 |
Homo sapiens |
IC50 |
= |
6300.0 |
nM |
PMID[564830] |
NPT668 |
Individual Protein |
P-glycoprotein 1 |
Homo sapiens |
IC50 |
= |
7200.0 |
nM |
PMID[564830] |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
28183.8 |
nM |
PMID[564817] |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
11220.2 |
nM |
PMID[564817] |
NPT317 |
Uncleic Acid |
Nucleic Acid |
|
Kd |
= |
2000.0 |
nM |
PMID[564831] |
NPT317 |
Uncleic Acid |
Nucleic Acid |
|
Kd |
= |
2190.0 |
nM |
PMID[564831] |
NPT317 |
Uncleic Acid |
Nucleic Acid |
|
Kd |
= |
1700.0 |
nM |
PMID[564831] |
NPT2 |
Others |
Unspecified |
|
Ratio Ki |
= |
52.0 |
n.a. |
PMID[564834] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
Hepatotoxicity (moderate) |
= |
2.0 |
n.a. |
PMID[564837] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
Hepatotoxicity (moderate) |
= |
0.0 |
% |
PMID[564837] |
NPT2 |
Others |
Unspecified |
|
Hepatotoxicity (acute) |
= |
5.0 |
n.a. |
PMID[564837] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
Hepatotoxicity (acute) |
= |
0.0 |
% |
PMID[564837] |
NPT2 |
Others |
Unspecified |
|
Hepatotoxicity (cytolytic) |
= |
0.0 |
n.a. |
PMID[564837] |
NPT2 |
Others |
Unspecified |
|
Hepatotoxicity (choleostasis) |
= |
4.0 |
n.a. |
PMID[564837] |
NPT2 |
Others |
Unspecified |
|
Hepatotoxicity (severe hepatitis) |
= |
0.0 |
n.a. |
PMID[564837] |
NPT2 |
Others |
Unspecified |
|
Hepatotoxicity (chronic liver disease) |
= |
0.0 |
n.a. |
PMID[564837] |
NPT2 |
Others |
Unspecified |
|
Hepatotoxicity (cirrhosis) |
= |
1.0 |
n.a. |
PMID[564837] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
Hepatotoxicity (granulomatous hepatitis) |
= |
0.0 |
n.a. |
PMID[564837] |
NPT2 |
Others |
Unspecified |
|
Hepatotoxicity (association with vascular disease) |
= |
0.0 |
n.a. |
PMID[564837] |
NPT2 |
Others |
Unspecified |
|
Hepatotoxicity (steatosis) |
= |
0.0 |
n.a. |
PMID[564837] |
NPT2 |
Others |
Unspecified |
|
Hepatotoxicity (malignant tumour) |
= |
0.0 |
n.a. |
PMID[564837] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
Hepatotoxicity (benign tumour) |
= |
0.0 |
n.a. |
PMID[564837] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
Potency |
n.a. |
1.1 |
nM |
PMID[564838] |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
22387.2 |
nM |
PMID[564817] |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
14125.4 |
nM |
PMID[564835] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
Potency |
n.a. |
472.8 |
nM |
PMID[564838] |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
22387.2 |
nM |
PMID[564835] |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
15848.9 |
nM |
PMID[564836] |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
12589.3 |
nM |
PMID[564804] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
Potency |
n.a. |
10.6 |
nM |
PMID[564838] |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
7943.3 |
nM |
PMID[564804] |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
7079.5 |
nM |
PMID[564836] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
Potency |
n.a. |
84.1 |
nM |
PMID[564838] |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
7943.3 |
nM |
PMID[564835] |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
3162.3 |
nM |
PMID[564806] |
NPT35 |
Others |
n.a. |
|
pKa |
= |
8.1 |
n.a. |
PMID[564839] |
NPT35 |
Others |
n.a. |
|
Rm |
= |
3.55 |
n.a. |
PMID[564839] |
NPT35 |
Others |
n.a. |
|
LogD7.4 |
n.a. |
4.31 |
n.a. |
PMID[564840] |
NPT27 |
Others |
Unspecified |
|
PPB |
n.a. |
99.19 |
% |
PMID[564840] |
NPT27 |
Others |
Unspecified |
|
PPB |
n.a. |
99.3 |
% |
PMID[564840] |
NPT2 |
Others |
Unspecified |
|
IC50 |
= |
60070.0 |
nM |
PMID[564841] |
NPT602 |
Organism |
Mycobacterium smegmatis |
Mycobacterium smegmatis |
MIC |
= |
64.0 |
ug.mL-1 |
PMID[564841] |
NPT115 |
Organism |
Mycobacterium tuberculosis H37Ra |
Mycobacterium tuberculosis H37Ra |
IC50 |
= |
8.0 |
ug.mL-1 |
PMID[564841] |
NPT2 |
Others |
Unspecified |
|
IC50 |
= |
12000.0 |
nM |
PMID[564841] |
NPT2 |
Others |
Unspecified |
|
INH |
= |
100.0 |
uM |
PMID[564841] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
IC50 |
= |
24540.0 |
nM |
PMID[564842] |
NPT844 |
Organism |
Trypanosoma brucei rhodesiense |
Trypanosoma brucei rhodesiense |
IC50 |
= |
1230.0 |
nM |
PMID[564842] |
NPT580 |
Organism |
Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
= |
10130.0 |
nM |
PMID[564842] |
NPT633 |
Organism |
Leishmania donovani |
Leishmania donovani |
IC50 |
= |
52930.0 |
nM |
PMID[564842] |
NPT633 |
Organism |
Leishmania donovani |
Leishmania donovani |
IC50 |
> |
7360.0 |
nM |
PMID[564842] |
NPT6 |
Organism |
Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
= |
1480.0 |
nM |
PMID[564842] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
IC50 |
= |
10990.0 |
nM |
PMID[564842] |
NPT27 |
Others |
Unspecified |
|
Ratio |
= |
144.0 |
n.a. |
PMID[564843] |
NPT27 |
Others |
Unspecified |
|
Ratio |
= |
0.9 |
n.a. |
PMID[564843] |
NPT27 |
Others |
Unspecified |
|
Papp |
= |
1.1 |
ucm/s |
PMID[564843] |
NPT27 |
Others |
Unspecified |
|
Papp |
= |
1.3 |
ucm/s |
PMID[564843] |
NPT27 |
Others |
Unspecified |
|
Ratio |
= |
1.9 |
n.a. |
PMID[564843] |
NPT632 |
Tissue |
Brain |
Rattus norvegicus |
Fu |
= |
0.0007 |
n.a. |
PMID[564844] |
NPT610 |
Others |
Molecular identity unknown |
|
Fu |
= |
0.0018 |
n.a. |
PMID[564844] |
NPT27 |
Others |
Unspecified |
|
Kd |
= |
392.0 |
nM |
PMID[564844] |
NPT27 |
Others |
Unspecified |
|
Papp |
= |
1.0 |
ucm/s |
PMID[564843] |
NPT610 |
Others |
Molecular identity unknown |
|
Fu |
= |
0.0033 |
n.a. |
PMID[564844] |
NPT27 |
Others |
Unspecified |
|
Ratio |
= |
2.6 |
n.a. |
PMID[564844] |
NPT27 |
Others |
Unspecified |
|
Papp |
= |
0.5 |
ucm/s |
PMID[564843] |
NPT605 |
Organism |
Homo sapiens |
Homo sapiens |
Fabs |
= |
16.0 |
% |
PMID[564843] |
NPT27 |
Others |
Unspecified |
|
Ratio |
= |
53.0 |
n.a. |
PMID[564843] |
NPT27 |
Others |
Unspecified |
|
Ratio |
= |
-16.0 |
n.a. |
PMID[564843] |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
44668.4 |
nM |
PMID[564817] |
NPT35 |
Others |
n.a. |
|
pKa |
= |
3.9 |
n.a. |
PMID[564847] |
NPT2 |
Others |
Unspecified |
|
IC50 |
= |
1140.0 |
nM |
PMID[564847] |
NPT2 |
Others |
Unspecified |
|
EC50 |
= |
5800.0 |
nM |
PMID[564847] |
NPT25303 |
PROTEIN COMPLEX |
Ubiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48 |
Homo sapiens |
IC50 |
= |
8000.0 |
nM |
PMID[564848] |
NPT713 |
Individual Protein |
Bile salt export pump |
Homo sapiens |
IC50 |
< |
10000.0 |
nM |
PMID[564849] |
NPT605 |
Organism |
Homo sapiens |
Homo sapiens |
Cmax |
= |
5.3 |
nM |
PMID[564849] |
NPT713 |
Individual Protein |
Bile salt export pump |
Homo sapiens |
IC50 |
< |
10000.0 |
nM |
PMID[564850] |
NPT605 |
Organism |
Homo sapiens |
Homo sapiens |
DILI_severity_class |
= |
2.0 |
n.a. |
PMID[564851] |
NPT2 |
Others |
Unspecified |
|
IC50 |
= |
50000.0 |
nM |
PMID[564852] |
NPT6 |
Organism |
Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
= |
1900.0 |
nM |
PMID[564853] |
NPT24751 |
CELL-LINE |
NSC |
n.a. |
Efficacy |
= |
21.0 |
% |
PMID[564854] |
NPT2 |
Others |
Unspecified |
|
Efficacy |
= |
85.0 |
% |
PMID[564854] |
NPT24751 |
CELL-LINE |
NSC |
n.a. |
IC50 |
= |
10100.0 |
nM |
PMID[564854] |
NPT2 |
Others |
Unspecified |
|
IC50 |
= |
10200.0 |
nM |
PMID[564854] |
NPT23714 |
CELL-LINE |
SUM-159-PT |
Homo sapiens |
IC50 |
= |
17030.0 |
nM |
PMID[564856] |
NPT23712 |
CELL-LINE |
KG-1a |
Homo sapiens |
IC50 |
= |
4580.0 |
nM |
PMID[564856] |
NPT23714 |
CELL-LINE |
SUM-159-PT |
Homo sapiens |
Activity |
= |
12.0 |
n.a. |
PMID[564856] |
NPT2 |
Others |
Unspecified |
|
IC50 |
= |
45000.0 |
nM |
PMID[564857] |
NPT2 |
Others |
Unspecified |
|
EC50 |
= |
1850.0 |
nM |
PMID[564858] |
NPT2 |
Others |
Unspecified |
|
EC50 |
= |
1340.0 |
nM |
PMID[564858] |
NPT20555 |
ORGANISM |
SARS-CoV-2 |
Severe acute respiratory syndrome coronavirus 2 |
IC50 |
n.a. |
6460.0 |
nM |
PMID[564859] |
NPT20555 |
ORGANISM |
SARS-CoV-2 |
Severe acute respiratory syndrome coronavirus 2 |
IC50 |
n.a. |
6456.54 |
nM |
PMID[564859] |
NPT20555 |
ORGANISM |
SARS-CoV-2 |
Severe acute respiratory syndrome coronavirus 2 |
IC50 |
> |
100000.0 |
nM |
PMID[564859] |
NPT22224 |
CELL-LINE |
Vero C1008 |
Chlorocebus sabaeus |
CC50 |
n.a. |
7940.0 |
nM |
PMID[564859] |
NPT22224 |
CELL-LINE |
Vero C1008 |
Chlorocebus sabaeus |
pCC50 |
n.a. |
5.1 |
n.a. |
PMID[564859] |
NPT27528 |
TISSUE |
Brain |
Homo sapiens |
Drug uptake |
= |
4.0 |
ug ml-1 |
PMID[564833] |